Seehra Jasbir - Insider Non-Derivative Transactions at Keros Therapeutics, Inc. (KROS) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Apr 8, 2023, Seehra Jasbir's relationship to Keros Therapeutics, Inc. (KROS) is Director,Officer (Chief Executive Officer), and currently has 252,856 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other KROS insiders.

Data Source: SEC.
Seehra Jasbir - Insider Non-Derivative Transactions of KROS Common Stock
Seehra Jasbir - Insider Non-Derivative Transactions at KROS
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Apr 9, 2023 M -- (Common Stock) 4000 0.48 252856